Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
Clinical trial NCT01990209 · COMPLETED
Trial details
- NCT number
- NCT01990209
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2021-05-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.